과제정보
This work was supported by a grant from the Korea Medical Device Development Fund, financed by the Korean government (including the Ministry of Science and ICT; the Ministry of Trade, Industry and Energy; the Ministry of Health & Welfare; and the Ministry of Food and Drug Safety) (Project no., 1711138313, KMDF_PR_20200901_0159).
참고문헌
- Neragi-Miandoab S, Linden PA, Ducko CT, et al. VATS pericardiotomy for patients with known malignancy and pericardial effusion: survival and prognosis of positive cytology and metastatic involvement of the pericardium: a case control study. Int J Surg 2008;6:110-4. https://doi.org/10.1016/j.ijsu.2007.12.005
- Bisel HF, Wroblewski F, Ladue JS. Incidence and clinical manifestations of cardiac metastases. J Am Med Assoc 1953;153:712-5. https://doi.org/10.1001/jama.1953.02940250018005
- Theologides A. Neoplastic cardiac tamponade. Semin Oncol 1978;5:181-92.
- Okamoto H, Shinkai T, Yamakido M, Saijo N. Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion. Cancer 1993;71:93-8. https://doi.org/10.1002/1097-0142(19930101)71:1<93::aid-cncr2820710115>3.0.co;2-r
- Hankins JR, Satterfield JR, Aisner J, Wiernik PH, McLaughlin JS. Pericardial window for malignant pericardial effusion. Ann Thorac Surg 1980;30:465-71. https://doi.org/10.1016/s0003-4975(10)61298-2
- Celermajer DS, Boyer MJ, Bailey BP, Tattersall MH. Pericardiocentesis for symptomatic malignant pericardial effusion: a study of 36 patients. Med J Aust 1991;154:19-22. https://doi.org/10.5694/j.1326-5377.1991.tb112840.x
- O'Brien PK, Kucharczuk JC, Marshall MB, et al. Comparative study of subxiphoid versus video-thoracoscopic pericardial "window". Ann Thorac Surg 2005;80:2013-9. https://doi.org/10.1016/j.athoracsur.2005.05.059
- Cullinane CA, Paz IB, Smith D, Carter N, Grannis FW Jr. Prognostic factors in the surgical management of pericardial effusion in the patient with concurrent malignancy. Chest 2004;125:1328-34. https:// doi.org/10.1378/chest.125.4.1328
- Celik S, Celik M, Aydemir B, Tanrikulu H, Okay T, Tanrikulu N. Surgical properties and survival of a pericardial window via left minithoracotomy for benign and malignant pericardial tamponade in cancer patients. World J Surg Oncol 2012;10:123. https://doi.org/10.1186/1477-7819-10-123
- Laham RJ, Cohen DJ, Kuntz RE, Baim DS, Lorell BH, Simons M. Pericardial effusion in patients with cancer: outcome with contemporary management strategies. Heart 1996;75:67-71. https://doi.org/10.1136/hrt.75.1.67
- Sakanoue I, Hamakawa H, Okubo Y, et al. Efficacy and safety of thoracoscopic pericardial window in patients with pericardial effusions: a single-center case series. J Cardiothorac Surg 2016;11:92. https://doi.org/10.1186/s13019-016-0488-x
- Jeon HW, Cho DG, Park JK, et al. Prognostic factors affecting survival of patients with cancer-related pericardial effusion managed by surgery. World J Surg Oncol 2014;12:249. https://doi.org/10.1186/1477-7819-12-249
- Gornik HL, Gerhard-Herman M, Beckman JA. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol 2005;23:5211-6. https://doi.org/10.1200/JCO.2005.00.745
- Olsen PS, Sorensen C, Andersen HO. Surgical treatment of large pericardial effusions. Etiology and long-term survival. Eur J Cardiothorac Surg 1991;5:430-2. https://doi.org/10.1016/1010-7940(91)90189-q
- Porte HL, Janecki-Delebecq TJ, Finzi L, Metois DG, Millaire A, Wurtz AJ. Pericardoscopy for primary management of pericardial effusion in cancer patients. Eur J Cardiothorac Surg 1999;16:287-91. https://doi.org/10.1016/s1010-7940(99)00204-3
- Ucche M, Putra A, Gustisiya MA, Choridah L, Supriatna Y, Dwidanarti SR, et al. Remarkable response to pericardial window procedure and weekly docetaxel treatment in a metastatic breast cancer patient with pericardial effusion and cardiac tamponade. Clin Case Rep 2020;8:3178-83. https://doi.org/10.1002/ccr3.3380
- Celik S, Lestuzzi C, Cervesato E, et al. Systemic chemotherapy in combination with pericardial window has better outcomes in malignant pericardial effusions. J Thorac Cardiovasc Surg 2014;148:2288-93. https://doi.org/10.1016/j.jtcvs.2014.04.031
- Tsang TS, Seward JB, Barnes ME, et al. Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Proc 2000;75:248-53. https://doi.org/10.4065/75.3.248
- Wagner PL, McAleer E, Stillwell E, et al. Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability. J Thorac Cardiovasc Surg 2011;141:34-8. https://doi.org/10.1016/j.jtcvs.2010.09.015
- DeCamp MM Jr, Mentzer SJ, Swanson SJ, Sugarbaker DJ. Malignant effusive disease of the pleura and pericardium. Chest 1997;112(4 Suppl):291S-295S. https://doi.org/10.1378/chest.112.4_supplement.291s